StockMarketWire.com - Antibiotics developer Motif Bio noted that substantial shareholder Amphion Innovations had agreed to repayment of a loan by one year until 30 September 2019.

Amphion's loan facility was secured by around 24.5m Motif shares.


At 9:59am: [LON:MTFB] Motif Bio Plc Ord 1p share price was +0.35p at 33.1p



Story provided by StockMarketWire.com